Health Care Products

The Food and Drug Administration oversees a broad range of medical and consumer products. In fact, the agency estimates that up to a quarter of all U.S. consumer spending is on FDA-regulated items. The Pew Charitable Trusts understands the tremendous impact these products have on public health. This project complements our work supporting drug safety and effective and efficient regulation of medical devices by focusing attention on over-the-counter drugs and dietary supplements, as well as fields such as regenerative medicine, in order to safeguard consumers and patients.

Our Work

View All
  • FDA Should Consider Public Health Implications of Supplement Ingredients List

    The Pew Charitable Trusts submitted comments to the Food and Drug Administration on Dec. 4 regarding the agency’s plan to create a list of dietary supplement ingredients that were on the market before passage of the Dietary Supplement Health and Education Act of 1994. Products containing ingredients that predate the legislation can be marketed without prior notice to FDA. Read More

  • Dietary Supplement Use in the Military

    Many service members take dietary supplements to enhance performance, build muscle, lose weight, or promote general well-being. Taking one or more of these products may be beneficial when a person does not get the recommended amount of nutrients from foods. Unfortunately, some supplements can cause serious injury or death. Dangerous supplements compromise the readiness of our armed forces and the... Read More

  • Industry Joins With Public Health Groups to Address Tainted Supplements

    Dietary supplements have grown in popularity, at least in part for their claims to boost nutrition and provide other health benefits. But many have been found to contain undisclosed active pharmaceutical ingredients or illegal substances, which can harm consumers. Unless a product contains a new dietary ingredient, the Food and Drug Administration lacks the authority to examine supplements before... Read More

Media Contact

Tami Holzman

Officer, Communications

202.552.2122